Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: November 2012
-
By Kevin E. Noonan — In a decision that should surprise no one, the U.S. Supreme Court granted certiorari today in Association for Molecular Pathology v. Myriad Genetics, Inc. The grant was limited to the first question presented, whether human genes are patent-eligible, and the Court denied certiorari on the other two questions (thus letting…
-
By Kevin E. Noonan — On Halloween, Myriad Genetics filed its brief in opposition to plaintiffs' petition for certiorari in Association for Molecular Pathology v. Myriad Genetics, Inc. (plaintiffs nominally being the Association for Molecular Pathology et al., but actually the American Civil Liberties Union and the Public Patent Foundation). In doing so, Myriad no doubt…
-
By Donald Zuhn — The U.S. Patent and Trademark Office recently released its Performance and Accountability Report for Fiscal Year (FY) 2012. The report notes that the Office's 2010-2015 Strategic Plan sets forth three strategic goals and one management goal in support of the Office's mission to foster innovation and competitiveness by providing high quality…
-
By Donald Zuhn — In an opinion issued earlier this month, Judge Ellen Segal Huvelle of the U.S. District Court for the District of Columbia determined that Novartis AG and Novartis Vaccines and Diagnostics, Inc. had not satisfied the 180-day limitation of 35 U.S.C. § 154(b)(4)(A) for timely challenging patent term adjustment (PTA) determinations of…
-
Patent Docs Makes List for First Time The ABA Journal has announced its annual list of the 100 best legal blogs — or blawgs — following a nomination process that began in August. The 100 blogs selected for the 2012 list have been divided into fifteen categories: News/Analysis, Trial Practice, Business of Law, Niche, For…
-
Is There Light at the End of the Tunnel? By Jenny Donald — It is clear from an emerging practice of the European Patent Office (EPO) that they were not widely impressed by the controversial Brüstle decision issued by the Court of Justice of the European Union (CJEU). The EPO has adapted its practice to…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Apotex Inc. v. Daiichi Sankyo, Inc. et al.1:12-cv-09295; filed November 20, 2012 in the Northern District of Illinois • Plaintiff: Apotex Inc.• Defendants: Daiichi Sankyo, Inc.; Daiichi Sankyo Co., Ltd. Declaratory judgment of non-infringement of…
-
November 27, 2012 – Patents and the Written Description Requirement: Navigating Section 112 Disclosure Obligations and Withstanding Invalidity Challenges (Strafford) – 1:00 – 2:30 pm (EST) November 28-29, 2012 – Biotech Patents*** (American Conference Institute) – Boston, MA November 28-29, 2012 – Orphan Drugs and Rare Diseases*** (American Conference Institute) – Boston, MA December 3-5,…
-
The U.S. Patent and Trademark Office will be holding a combined customer partnership meeting of Technology Center 3700 (medical devices) and Technology Center 1600 (biotechnology) on January 29, 2013. The agenda for the meeting is as follows: • Sign-in — 8:30 – 9:00 am• Introduction — 9:00 – 9:30 am• CPC (Cooperative Patent Classification) —…
-
The authors and contributors of Patent Docs wish their readers and families a Happy Thanksgiving. Publication of Patent Docs will resume on November 23rd.
Patent Docs 